J
J. Pariente
Researcher at Centre Hospitalier Universitaire de Toulouse
Publications - 19
Citations - 526
J. Pariente is an academic researcher from Centre Hospitalier Universitaire de Toulouse. The author has contributed to research in topics: Stroke & Autoimmune encephalitis. The author has an hindex of 9, co-authored 19 publications receiving 309 citations. Previous affiliations of J. Pariente include Aix-Marseille University & Paul Sabatier University.
Papers
More filters
Journal ArticleDOI
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Stephen Salloway,Martin R. Farlow,Eric McDade,David B. Clifford,Guoqiao Wang,Jorge J. Llibre-Guerra,Janice M. Hitchcock,Susan Mills,Anna Santacruz,Andrew J. Aschenbrenner,Jason Hassenstab,Tammie L.S. Benzinger,Brian A. Gordon,Anne M. Fagan,Kelley Coalier,Carlos Cruchaga,Alison Goate,Richard J. Perrin,Chengjie Xiong,Yan Li,John C. Morris,B. Joy Snider,Catherine J. Mummery,G. Mustafa Surti,Didier Hannequin,David Wallon,Sarah B. Berman,James J. Lah,Ivonne Z. Jimenez-Velazquez,Erik D. Roberson,Christopher H. van Dyck,Lawrence S. Honig,Raquel Sánchez-Valle,William S. Brooks,Serge Gauthier,Douglas Galasko,Colin L. Masters,Jared R. Brosch,Ging-Yuek Robin Hsiung,Suman Jayadev,Maïté Formaglio,Mario Masellis,Roger Clarnette,J. Pariente,Bruno Dubois,Florence Pasquier,Clifford R. Jack,Robert A. Koeppe,Peter J. Snyder,Paul S. Aisen,Ronald G. Thomas,Scott M. Berry,Barbara A. Wendelberger,Scott W. Andersen,Karen C. Holdridge,Mark A. Mintun,Roy Yaari,John R. Sims,Monika Baudler,Paul Delmar,Rachelle S. Doody,Paulo Fontoura,Caroline Giacobino,Geoffrey A. Kerchner,Randall J. Bateman +64 more
TL;DR: A randomized, placebo-controlled, multi-arm trial of gantenerumab or solanezumab in participants with DIAD across asymptomatic and symptomatic disease stages was conducted in this paper.
Journal ArticleDOI
COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network.
Louis Delamarre,Cédric Gollion,Gaspard Grouteau,David Rousset,Guillaume Jimena,Jérôme Roustan,François Gaussiat,Etienne Aldigé,Charlène Gaffard,Julien Duplantier,Charlotte Martin,Olivier Fourcade,Chloé Bost,Françoise Fortenfant,Pierre Delobel,Guillaume Martin-Blondel,J. Pariente,Fabrice Bonneville,Thomas Geeraerts +18 more
TL;DR: Clinical, biological, radiological and immunological features of a COVID-19 patient case, evocative of virus-associated acute necrotising encephalopathy (ANE) possibly mediated by antibodies are presented.
Journal ArticleDOI
Methylphenidate modulates cerebral post-stroke reorganization
J. Tardy,J. Pariente,Anne Leger,Sophie Dechaumont-Palacin,Angélique Gerdelat,Vincent Guiraud,Fabrice Conchou,Jean-François Albucher,Philippe Marque,Xavier Franceries,Christophe Cognard,Olivier Rascol,François Chollet,Isabelle Loubinoux +13 more
TL;DR: It is demonstrated that the reorganized network may efficiently be targeted by the drug and that the effect of MP might partly rely on an improvement in attention/effort through cingulum modulation.
Journal ArticleDOI
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI)
Pradeep J. Nathan,Yen Ying Lim,Rosemary A. Abbott,Samantha Galluzzi,Moira Marizzoni,Claudio Babiloni,Diego Albani,David Bartrés-Faz,Mira Didic,Lucia Farotti,Lucilla Parnetti,Nicola Salvadori,Bernhard W. Müller,Gianluigi Forloni,Nicola Girtler,Tilman Hensch,Jorge Jovicich,Annebet E. Leeuwis,Camillo Marra,José Luis Molinuevo,Flavio Nobili,J. Pariente,Pierre Payoux,Jean-Philippe Ranjeva,Elena Rolandi,Paolo Maria Rossini,Peter Schönknecht,Andrea Soricelli,Magda Tsolaki,Pieter Jelle Visser,Jens Wiltfang,Jens Wiltfang,Jill C. Richardson,Régis Bordet,Olivier Blin,Giovanni B. Frisoni +35 more
TL;DR: It is suggested that biomarkers of Aβ and tau are strongly related to cognitive performance as assessed by the CANTAB, and have implications for the early detection and characterization of incipient AD.
Journal ArticleDOI
Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
Mathieu Ceccaldi,Thérèse Rivasseau Jonveaux,Antoine Verger,Pierre Krolak-Salmon,Claire Houzard,Olivier Godefroy,Trevor Shields,Audrey Perrotin,Rossella Gismondi,Santiago Bullich,Aleksandar Jovalekic,Nicola Raffa,Florence Pasquier,Franck Semah,Bruno Dubois,Marie-Odile Habert,David Wallon,Mathieu Chastan,Pierre Payoux,Eric Guedj,Olivier Felician,Mira Didic,Claude Guériot,Lejla Koric,Radka Kletchkova-Gantchev,Daniela Andriuta,Agnès Devendeville,Diane Dupuis,Ingrid Binot,Mélanie Barbay,Marc-Etienne Meyer,Véronique Moullard,Eloi Magnin,Ludivine Chamard,Sophie Haffen,Olivier Morel,Clément Drouet,Hatem Boulahdour,Philippe Goas,Solène Querellou-Lefranc,Vincent de la Sayette,Julien Cogez,Pierre Branger,Denis Agostini,Alain Manrique,Olivier Rouaud,Yannick Béjot,Agnès Jacquin-Piques,Inna Dygai-Cochet,Alina Berriolo-Riedinger,Olivier Moreaud,Mathilde Sauvée,Céline Gallazzani Crépin,Stéphanie Bombois,Thibaud Lebouvier,Marie-Anne Mackowiak-Cordoliani,Vincent Deramecourt,Adeline Rollin-Sillaire,Pascaline Cassagnaud-Thuillet,Yaohua Chen,Grégory Petyt,Denis Federico,Keren Liora Danaila,Yves Guilhermet,Christophe Magnier,Zaza Makaroff,Isabelle Rouch,Jing Xie,Caroline Roubaud,Marie-Hélène Coste,Kenny David,Alain Sarciron,Aziza Sediq Waissi,Christian Scheiber,Audrey Gabelle-Deloustal,Karim Bennys,Cecilia Marelli,Lynda Touati,Denis Mariano-Goulart,Delphine de Verbizier-Lonjon,Athanase Benetos,Anna Kearney-Schwartz,Christine Perret-Guillaume,Martine Vercelletto,Claire Boutoleau-Bretonnière,Hélène Pouclet-Courtemanche,Nathalie Wagemann,Amandine Pallardy,Jacques Hugon,Claire Paquet,Julien Dumurgier,Pascal Millet,Mathieu Queneau,Stéphane Epelbaum,Marcel Levy,Jean-Luc Novella,Yacine Jaidi,Dimitri Papathanassiou,David Morland,Serge Belliard,Anne Salmon,Florence Lejeune,Didier Hannequin,Olivier Martinaud,Aline Zarea,J. Pariente,Claire Thalamas,Monique Galitzky-Gerber,Anne-Marie Tricoire Ricard,Fabienne Calvas,Emilie Rigal,Anne Hitzel,Julien Delrieu,Pierre-Jean Ousset,Françoise Lala,Nathalie Sastre-Hengan,Andrew W. Stephens +116 more
TL;DR: Although some studies have previously addressed the clinical impact of amyloid positron emission tomography, none has specifically addressed its selective and hierarchical implementation in relation to cerebrospinal fluid analysis in a naturalistic setting.